04:20 PM EDT, 07/20/2026 (MT Newswires) -- Maravai Lifesciences ( MRVI ) said late Monday its unit TriLink BioTechnologies secured a new patent from the China National Intellectual Property Administration related to its methods of synthesizing RNA molecules.

The new patent covers TriLink's CleanCap capping analogs, including its latest M6 analog, the company said.

CleanCap technology is a component of the production of synthetic mRNA, according to a statement.